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Repair of bone deficiencies in the craniofacial skeleton remains a difficult clinical problem. The aim of this study
was to evaluate a novel albumin scaffold seeded with human alveolar osteoblasts and implanted into experi-
mental mandibular defects. An experimental solid protein scaffold was prepared with human plasmatic albumin
crossed with a glutaraldehyde-type agent. Microstructure of scaffold and mechanical properties were examined
using scanning electron microscopy and a stress-controlled rheometer. Bilateral critical mandibular defects were
created in eight immunodeficient rats. Defects of the right side of the mandibles received the cell–scaffold
construct in all animals. All left mandibular defects were left untreated as blank controls. Sections of the defects
were collected at 5, 8, and 11 weeks postsurgery and processed for histological and immunohistochemical
observation, computed tomography examination, and computed tomography digital analysis. Histologically,
bone formation was observed in both groups at 5 weeks postsurgery, and the engineered bone became more
mature after 8 and 11 weeks, which was similar to normal bone. The origin of bone-forming cells within the
defects and the localization of implanted human osteoblasts were confirmed by human vimentin expression. No
bone formation could be observed at any control defect. Bone density after 8 weeks was significantly higher than
that of the 5-week group (p¼ 0.02), and significant differences were also observed between 8 and 11 weeks
( p< 0.01). The results indicate the clinical feasibility of albumin scaffold loaded with human alveolar cells and
that it can be used as a good alternative for bone regeneration.
Introduction
Successful repair of bone deficiencies in the cranio-facial skeleton, whether arising from trauma, tumor
resection, or congenital disorders, continues to be a major
concern to reconstructive surgeons. The use of autologous
bone grafts is considered to be the golden standard for repair
and reconstruction of bone.1,2 Otherwise, tissue-engineering
principles applied to skeletal reconstruction may improve
both morphologic and functional results while eliminating
main disadvantages.
Scaffolds play an essential role in supporting bone re-
generation in bone tissue engineering. Several scaffolds have
been developed, including polymethylmethacrylate, porous
polyethylene, hydroxyapatite, and tricalcium phosphate.
Despite their utility, as foreign bodies, these alloplastic ma-
terials may have inherent disadvantages, including increased
rates of infection and extrusion.3 Otherwise, plasma-derived
hydrogels are a class of biomaterials that have great scaf-
folding potential and have been in many tissue-engineering
applications. An essential advantage is the production from
the patient’s own blood and used as an autologous scaffold
without the potential risk of foreign body reaction or infec-
tion. The main disadvantage in craniomaxillofacial skeletal
reconstruction is the low mechanical stiffness.4
Because bone is always under continuous stress, the me-
chanical properties of the implanted construct should ideally
match those of living bone, so that an early mobilization of
the injured site can be made possible. Otherwise, the scaf-
folds degradation rate must be tuned appropriately with the
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growth rate of the neotissue, in such a way that by the time
the injury site is totally regenerated, the scaffold is totally
degraded.5
Physical and biological characteristics of plasma clot can
be improved by crosslinking plasma albumin with glutaral-
dehyde to form a novel scaffold easily obtained from auto-
logous serum.6 This method was used for development of
surgical glues7 with limited mechanical strength that can be
improved after a lyophilization process.6 Thus, the specific
characteristics of plasmatic proteins can be used to create a
new carrier with unique structural and mechanical proper-
ties. The scaffold developed in this study has a solid struc-
ture and slow degradation rate that makes it suitable for
management in craniofacial surgery. This experimental scaf-
fold with a inexpensive production could be appropriate for
bone regeneration.
To pursue the possibility of repairing maxillary bone de-
fect with tissue-engineered bone, we cultured human alve-
olar osteoblasts and then seeded them in this new type of
scaffold. In the present study, the hypothesis tested was that
cell–scaffold constructs transplanted into mandibular critical-
sized defects can retain their osteogenic properties and in-
duce new bone formation in immunocompromised rats.
Materials and Methods
Scaffold fabrication
To prepare the scaffold, 10mL venous blood was obtained
from the blood bank laboratories (Centro Comunitario de
Sangre y Tejidos, Asturias, Spain). The blood sample was
maintained 30min at 378C for fibrine clot retraction. Next,
the blood was subjected to centrifugation for 15min at
3000 rpm. The obtained serum (5mL) was crosslinked with
0.5mL 25% glutaraldehyde (Merck, Darmstadt, Germany)
and was transferred to 5mL disposable injection syringe. The
serum=glutaraldehyde solution was maintained at room
temperature for 30min until solidification. Then, the solution
was transferred to the freezing machine and kept at 708C
overnight. After that, the syringe was cut and the frozen
solution was lyophilized for 48 h and rehydrated in graded
ethanol (100%–90%–80%), 1 h in each one. The cylindrical
sponge obtained was then cut into 5-mm-diameter, 2-mm-
thick sections and sterilized with 70% ethanol for 8 h. Finally,
the scaffold was neutralized in the culture medium com-
prising Dulbecco’s modified Eagle’s medium (DMEM; Bio-
chrom, Berlin, Germany). Before cell seeding, excess fluid
was removed and the sponges were placed in a 24-well
culture plate, one sponge per well.
Microstructure observation and mechanical test
The microscopic structures of the novel albumin scaffold
in cross and longitudinal sections were examined using a
scanning electron microscope (SEM). Samples of the experi-
mental scaffold were sputter-coated with gold, and then
viewed using the SEM (JEOL JSM 6100, Tokyo, Japan). Pores
were measured in a perpendicular direction through the long
and minor axes.
Mechanical test was conducted using a stress-controlled
rheometer (Bohlin CS-10, East Brunswick, NJ) with a CP 4=40
cone-plate geometry (plate diameter 40mm). The stress
applied ranged from 101 to 300 Pa. The strain and stress
curves were obtained to evaluate the elastic modulus, vis-
cous modulus, and s critical point.
Isolation and culture of osteoblasts from alveolar bone
Normal human bone specimens were obtained from
healthy young patients who underwent oral surgery, free of
bone-related disease. The cortico-cancellous bone retrieved
had no soft tissue attachments and only minimal amounts of
retained blood. The biopsy was washed extensively in
phosphate-buffered saline (Gibco Life Technologies, Grand
Island, NY), cut into pieces of approximately 22mm, and
seeded onto 12.5-cm2 polystyrene flasks in 3mL of standard
culture medium consisting of DMEM (Biochrom) supple-
mented with 10% fetal bovine serum (FBS), 1% 200mM
l-glutamine, 100U=mL penicillin, and 100 mg=mL strepto-
mycin (Gibco Life Technologies). Cells were cultured until
confluence in a controlled atmosphere (5% CO2, 95% air, and
378C). The bone fragments were removed after 2 weeks, and
cells were passaged with trypsin–ethylenediaminetetraacetic
acid solution (Gibco Life Technologies) and plated in 25-cm2
culture flasks.
Cell seeding
Confluent cultures of osteoblasts were trypsinized and
counted using an improved Neubauer hemocytometer. The
released cells were suspended in DMEMwith 10% FBS. Then,
DMEM was removed and cells were seeded in scaffold with
osteogenic culture medium that consists of DMEM (Bio-
chrom) supplemented with 10 nM dexamethasone, 10mM
b-glycerophosphate, 0.28mM ascorbic acid (all from Sigma,
St. Louis, MO), and 10% FBS. Aliquots (100mL) of cells at
a density of 5,000,000 cells=mL were seeded onto albumin
scaffold sponges (5mm in diameter and 2mm thick). The
culture medium was changed two times per week. The cells
were maintained for 1 month at 378C in a fully humidified
atmosphere at 5% CO2 in air.
Surgical procedure
While performing this study we followed the rules of
Declaration of Helsinki for the care and use of laboratory
animals. We used eight 11- to 12-week-old nude rats
(rnu=rnu, Crl: NIH-Foxn1) weighing between 250 and 270 g.
They were kept in proper environment under natural light-
ing and temperature, and fed water and ration ad libitum.
The animals were anesthetized with an intramuscular
administration of pentobarbital sodium (0.038mg=g) and
xylazine hydrochloride (0.075mg=g). A submandibular in-
cision was made through the skin, subcutaneous tissue, and
masseter muscle paralleling the inferior border of the man-
dible. The buccal and lingual surfaces of the mandible were
exposed with an elevator, and two bilateral 55-mm full-
thickness critical defects were created in the body of the
mandible in each animal.8–10 Defects were created with a
trephine bur in a slow-speed dental drill. To prevent over-
heating, 0.9% physiological saline was dropped onto the
contact point between the bur and bone.
The critical-sized defects of right side of each mandible
were subsequently filled with cell–scaffold constructs. The
implant was trimmed to fit the defect and placed precisely
into the defects, and soft tissue above the defect was closed
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with 4-0 Vicryl sutures (Ethicon, Lenneke Marelaan, Bel-
gium). The periosteum was removed completely. To ensure
that the bone defects were critical-sized, left mandibular
defects were left untreated as blank controls in both groups.
Two animals were sacrificed at 5, 8, and 11 weeks postop-
eratively, and their mandibles were harvested.
Computed tomography examination
Two animals were sacrificed and theirmandibles evaluated
after 5, 8, and 11 weeks, respectively. Defects of the same size
on the left sides of themandibles served as empty controls. The
morphology of the implanted mandibles was assessed using
computed tomography (CT; Toshiba Aquilion 16; Toshiba
Medical Systems Corporation, Tochigi, Japan) with the fol-
lowing operating parameters: small target, 120 kV, 125mA,
1-s scanning time, and 0.5-mm section thickness. Mandibles
were observed in a pseudo three-dimensional display.
CT images digital analysis
CT images were analyzed by a Leica Qwin Pro image
analysis system (Leica Microsystem Imaging Solutions,
Cambridge, United Kingdom) to detect the areas of bone in-
growthwithin the defects. The implanted areawas designated
as the region of interest. The image analysis program then
measured both the surface area of this region and the sur-
rounding normal bone area. The Leica QWin generates data
by analyzing relative pixel values of selected areas. To quan-
tify the calcification of repaired mandibles, CT images were
binarized by an automatic threshold based on the histogram
frequency distribution of gray levels (0, black; 100, white).
The values represent arbitrary units and correspond directly
to the radiopacity of the CT images, thus reflecting the degree
of bone fillwithin the bone defect. All resultswere entered into
a spreadsheet (EXCEL version 5.0; Microsoft, Madrid, Spain).
Bone ingrowth was evaluated at different points postsurgery.
Statistical analysis
Data from digital analysis were analyzed by one-way
analysis of variance (ANOVA) test, using SPSS 13.0 (SPSS,
Chicago, IL). The differences between 5, 8, and 11 weeks
were assessed with ANOVA and Bonferroni test. A p-value
less than 0.05 was considered statistically significant.
In vivo histological analysis
Bone samples at 5, 8, and 11 weeks were infiltrated with
and embedded in polymethylmethacrylate. Sectioning was
performed with a rotating diamond wafering saw (Buehler,
Lake Bluff, IL). The saw excursion was 900 mm for each sec-
tion, with approximately half of this thickness being absorbed
by the blade width. The sections were then mounted on
plastic slides (Wasatch Histo Consultants, Winnemucca, NV),
ground to a thickness of 100 mm or less, and polished. The
sections were stained with hematoxylin and eosin or by von
Kossa silver nitrate staining, and counterstainedwith safranin
(Sigma), according to the manufacturer’s instruction.
Immunohistochemistry
The origin of bone-forming cells within the transplants
was confirmed through human vimentin expression. Small
samples of implanted areas 11 weeks after surgery were
fixed and stored in 4% paraformaldehyde until ready for
paraffin embedding. To examine human vimentin expression
immunohistochemically, endogenous peroxidase was quen-
ched by incubating with 1% H2O2 and methanol. The par-
affin sections were incubated with human-specific vimentin
(Novocastra, 50-fold dilution, NCL-L-VIM-V9). Color reac-
tion was developed with hematoxylin.
Results
Microstructure observation and mechanical test
The microscopic structures of the albumin scaffold were
examined using the SEM. Pore size ranged from 150 to
300mm in cross sections and 300 to 500mm in longitudinal
sections. Irregular size and shape of sheet-like structure was
observed, and almost all pores were interconnected (Fig. 1).
Critical sigma (sc) is defined by the greatest stress value
before definitive deformation. This parameter was found by
determining stress at the point of greatest slope in the most
linear portion of the curve (viscoelastic linear region). For the
experimental albumin scaffold, sc was 22 Pa. We measured
elastic modulus (G0) and viscous modulus (G0 0). In all our
samples G0 was greater than G0 0, indicating that this scaffold
present a more elastic than viscous behavior (Fig. 2).
Clinical evaluation
During the experiment, two animals died after 2 and 5 days
postsurgery, respectively, of unknown causes. The six re-
maining animals were fed a pureed diet and exhibited a
normal pattern of activity. Clinical healing was uneventful,
with limited signs of inflammation. All surgical wounds re-
mained closed without any signs of material exposure during
the healing period. Five, 8, and 11 weeks after implantation
two rats were sacrificed, respectively. After dissection to the
bony mandible, bone formation could be seen macroscopi-
cally in all specimens at implanted region (right). On the
contrary, no bony union was observed at control region (left),
and obvious soft tissue was detected in the original defect
area.
CT examination
To follow-up the new bone formation and the develop-
ment of bone union within the defects, CT images were taken
at 5, 8, and 11 weeks postoperation. Empty control defects
(left side) remained unfilled during the entire observation
period. Cell–scaffold constructs had induced bone regener-
ation on the right side of the mandibles after 5 weeks. After 8
and 11 weeks, implanted defects appeared similar in char-
acter to adjacent native bone, and the margins of the defects
could not be delineated (Fig. 3). Implants had induced bone
formation at different points after surgery that was found to
be grossly maintained on pseudo three-dimensional displays
from week 5 to 11.
CT digital analysis
As quantified by CT digital analysis, bone density values
of the defects filled with osteoblasts–scaffold constructs were
significantly greater than either unfilled bone defects (all
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FIG. 1. Scanning electron microscopy images show microstructures of the albumin scaffold on cross sections (a–d) and
longitudinal sections (e–h). The black regions represent voids, and gray or white regions represent scaffold. Original mag-
nification: (a, e),25; (b, f),50; (c, g),100; (d, h),200.
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control defects had values close to 0). Range values and
mean of each group can be observed in Table 1.
Samples were analyzed at three time points, 5, 8, and 11
weeks, after scaffold implantation. At 8 weeks, bone forma-
tion in implanted defects was significantly higher than that
of the 5-week group (p¼ 0.02, statistically tested by ANOVA
post hoc), and significant differences were also observed
between 8 and 11 weeks ( p< 0.01, statistically tested by
ANOVA post hoc) (Fig. 4).
In vivo histological analysis
To observe the general process of alveolar bone regener-
ation in vivo, histological study was performed on two ani-
mals sacrificed at 5, 8, and 11 weeks, respectively. In control
regions (left side) there was no evident bone regenera-
tion even at 11 weeks postsurgery. In contrast, osteoblast-
containing transplants contained abundant new bone firmly
attached to scaffold and the adjacent rat bone. The section of
specimens at 5 weeks postsurgery showed new bone com-
posed of irregular bone without a mature Haversian system
(Fig. 5a). There was basophilic mineralization throughout
that was proved with von Kossa staining (Fig. 5d). There was
not an evident interface between the newly regenerated bone
and the host bone. After 8 weeks, spaces inside the implant
created by scaffold degradation were filled by ingrowth of
newly formed bone (Fig. 5b, e). After 11 weeks, degradation
of the scaffold was considerably advanced with simulta-
neous bone fill of the resulting cavities (Fig. 5c, f ). Therefore,
the most significant difference between early and late
FIG. 2. Viscoelastic modulus as a function of shear stress
amplitude in mechanical test for experimental albumin
scaffold. Color images available online at www.liebertonline
.com=ten.
FIG. 3. Computed tomography images of treated and
control defects taken at different time points post-operation.
Radiolucency and minimal bone formation were observed in
hemimandibles placed at the right side of each image (con-
trol). White arrows indicate area of repaired defect.
Table 1. Bone Densities of the Defects Filled
with Osteoblast–Scaffold Constructs at Different
Time Points and Host Bone Based on Digital
Analysis of Computed Tomography Images











Values shown are mean (minimum–maximum).
FIG. 4. Computed tomography images were analyzed
using an automatic threshold based on the histogram fre-
quency distribution of gray levels (0, black; 100, white).
Samples were analyzed at 5, 8, and 11 weeks postsurgery. At
8 weeks, bone density was significantly higher than that of
the 5-week group (p¼ 0.02), and significant differences were
also observed between 8 and 11 weeks ( p< 0.01).
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transplants was a visible reduction in the volume of residual
scaffold among the late transplants and a corresponding in-
crease in the amount of new bone, suggesting resorption of
the particles and replacement with mineralized tissue.
Immunohistochemistry
The origin of bone-forming cells within the defects and
the localization of implanted human osteoblasts were deter-
mined by human vimentin expression. It was unknown
whether transplanted human osteoblasts contributed to the
bone formation, because host (rat) cells could have induced
bone formation in response to protein scaffold. Anti-human
vimentin served as a marker for donor cell activity because it
is not present in the recipient rat cells. The positively labeled
cells were nearly all located inside and around the scaffold,
with stronger expression surrounding the new-formed bone.
However, these cells were surrounded by negatively stained
FIG. 5. Histological evaluation of tissue reaction at different time points postimplantation of osteoblasts in bone defects. (a–c)
Hematoxylin–eosin stain; (d–f) von Kossa stain. (a) Five weeks after surgery, there was basophilic mineralization adjacent to
scaffold. (b) Eight weeks postsurgery, the structure of newly formed bone was remolded to the structure similar to that of
surrounding, and bone degradation of the scaffold was considerably advanced. (c) Eleven weeks postsurgery, the structure of
new bone is almost the same as normal bone, and scaffold could not be identified in most samples. (d) Five weeks postsurgery,
mineralized areas stained in brown embedded in extracellular matrix were observed near the scaffold. (e) Eight weeks after
implantation, spaces inside the implant created by scaffold degradation had been filled by ingrowth of newly formed bone. (f)
Eleven weeks after surgery, scaffold was almost completely degraded and replaced with mineralized tissue (black arrows and
white arrows indicate scaffold; magnification,100). Color images available online at www.liebertonline.com=ten.
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cells embedded among the porous of the spongy scaffold
(Fig. 6).
Discussion
Although autologous bone grafts and the free flap tech-
nique still remain the standard in reconstruction of man-
dibular lesions, tissue engineering is a promising option to
existing surgical procedures.11 In contrast to a large autog-
enous bone graft, tissue engineering requires only a small
amount of alveolar cells to create new functional tissue. The
current study demonstrates that the critical-sized defects of
the rat mandible can be repaired by albumin serum-derived
scaffold seeded with human-cultured osteoblasts obtained
from a small cancellous bone sample. When this novel al-
bumin scaffold construct was implanted into critical-sized
defects in nude rat mandible, it was capable of differentiating
to form bone matrix and of mineralizing trabeculae of bone
within the defects.
Mandibular reconstruction using tissue engineering has
been evaluated in a number of experimental models with a
large variety of carriers and different types of cells.11–17
Biodegradable scaffold plays a pivotal role in bone engi-
neering. The scaffold can provide a skeletal support for the
growth of osteogenic cells at early stage and create enough
space for new bone formation when they are degraded at
later time point.18–20
The most widely used forms of serum-derived scaffolds
are fibrin hydrogels, fibrin glue, and fibrin microbeads.4
Platelet-rich fibrin glue has also been used as a scaffold for
bone tissue engineering.21 Newly formed bone from osteo-
blastic cells suspended in hydrogels has been widely dem-
onstrated.22–28 As hydrogel–cell constructs lack adequate
initial strength, usually they require additional mechanical
support for the implantation of engineered bone in a weight-
bearing position. In most of these studies, combination of
fibrin scaffold with other materials, such as hyaluronic acid,
hydroxyapatite, or calcium phosphate was necessary for
improving mechanical properties.22,24,28 The main goal
of this study was to develop a solid human serum-derived
scaffold for skeletal bone engineering. Otherwise, there is
evidence that surgical glues could be potentially harmful to
local tissue and generate a local inflammatory reaction.7
Moreover, toxicity of the crosslinking agent glutaraldehyde
usually does not allow cell culture. Our technique using a
lyophilization process after crosslinking reduces and almost
eliminates toxic properties of this agent. Osteoblasts could
grow and maintain their activity when seeded in this novel
albumin scaffold, and no inflammatory reaction could be
macroscopic or histologically observed in rats. Our results
suggest that the albumin scaffold developed is an appro-
priate carrier for bone tissue development and can poten-
tially be used as an autologous scaffold. Further, the easy
and nonexpensive production of scaffold makes it suitable
for repair bone defects.
Pore structure is very important when considering scaf-
folds for tissue engineering. High porosity and well-
connected pores create good mass transfer properties and
increase cell viability. A porous scaffold microstructure with
minimal pore size ranging from 100 to 150 mm is usually
required to allow tissue ingrowth.20 Pore size ranged from
150 to 500 mm and showed a larger pore size on longitudinal
section than on cross section of the novel albumin scaffold.
The pores were highly interconnected and elongated in
shape. Thus, this experimental scaffold has an appropriate
architecture that allowed cellular penetration, extracellular
matrix production, and neovascularization.
Different types of cells have been used for bone engi-
neering, including adiposal stromal cells,29 periosteal cells,30
bone marrow stromal cells,12 induced pluripotent stem
cells,31 and cells derived directly from bone.13 The relatively
simple harvesting of bone marrow cells or osteoblasts from
an easily accessible bone site, such as the alveolar bone of the
jaw, can provide a good source of autologous bone tissue.
The clinical relevance of alveolar bone as a cell source rests
on the possibility of obtaining easily a small amount of bi-
ological material from a simple biopsy, without important
damage to the donor site.32 Otherwise, mandibular alveolar
bone is one of the most active bones in human body and may
be a useful site for harvesting mature osteoblasts for bone
engineering purposes in the oral cavity.
Ideal seed cells for bone tissue engineering should be able
to proliferate quickly, function like osteoblasts, be non-
immunogenic when implanted in vivo, and be biocompatible
FIG. 6. Expression of human-specific vimentin in tissue sections with osteoblast implantation 11 weeks after surgery.
Vimentin expression was evident inside and around the scaffold. Cells were surrounded by negatively stained cells (black
arrows indicate human vimentin stained cells; magnification, 200). Color images available online at www.liebertonline
.com=ten.
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to scaffold materials.1,2,33 Previous studies have shown that
human alveolar osteoblasts can be easily expanded during
in vitro culture34–37 and maintain osteogenic potential
in vivo.11–17 Otherwise, alveolar bone is an easily accessible
site for harvesting bone cells in the oral cavity. As the use of
determined osteoblastic cells do not raise legal issues and
there are no problems of immune rejection (as long as the
source is autologous), determined osteoblasts can be con-
sidered one of the most important cell sources in cell-based
bone reconstruction therapies at present.38 Consistent with
these works, we demonstrated that human osteoblasts were
capable of closing critical-sized rat mandibular defects when
placed in conjunction with a new-developed scaffold. Digital
image analysis and histological examination showed that
after 11 weeks of implantation pore fill and total bone surface
area were significantly higher than those after 8 and 5 weeks.
This confirms a progressive osteoblast activity in implanted
areas. New bone formation in the defect and the formation of
bone islands appeared to arise from both the transplanted
osteoblasts (as judged by their staining for the human-
specific vimentin) and the host cells (as judged by their
negative staining for the anti-human vimentin). Cell con-
structs with differentiated osteoblasts and serum-derived
scaffolds could not have been only involved in direct bone
formation, but also appear to be osteoinductive, inducing
differentiation and osteogenesis potential of host cells during
the repair of the critical-sized bone defects.
The morphologic findings after 11 weeks with advanced
scaffold degradation suggest that the carrier is gradually
replaced by the new-formed bone. The matrix maintained its
overall shape and silhouette after placement, not requiring
fixation to stay in place. Particles did not migrate away from
the transplant, suggesting that these particles maintain co-
hesion.
In this study, serum used for scaffold fabrication was
obtained from the blood bank laboratories (Centro Comu-
nitario de Sangre y Tejidos, Asturias, Spain), but future in-
vestigations will have to focus on the development of a
completely autologous construct to promote the regeneration
of hard tissue. In comparison with other commercial serum-
derived scaffolds, this carrier provides an appropriate me-
chanical strength for craniomaxillofacial reconstruction. An
extremely easy and cheap fabrication may represent an es-
sential advantage of this new scaffold.
In conclusion, this preliminary study demonstrates that a
new human serum-derived spongy scaffold loaded with
human alveolar osteoblasts can repair the critical-sized
mandibular defects in nude rats. The satisfactory repair rate
suggests that this might be a feasible approach for the clinical
reconstruction of craniomaxillofacial bone defects. This
scaffold could represent a promising tool for bone repair or
augmentation in the future. However, more in vitro and
in vivo investigations are still needed to prove safety and
potential of this scaffold. Future work will concentrate on
further evaluation of osteogenesis in this albumin scaffold
implanted in segmental mandibular defects in an animal
model.
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